Summary
- Bed Bath & Beyond announced fiscal Q4 results slightly above the guidance.
- The long-term outlook is confirmed, but the guidance for fiscal Q1 is disappointing.
- The recent results and the threats contrast with management's optimism.
- If management delivers as announced, the company is undervalued. But, considering the competition, I'm more prudent, and I prefer to stay on the sidelines.
With public actions from activist investors, Bed Bath & Beyond's (BBBY) stock price increased 85%+ from the Christmas selloff. Also, management announced slightly better-than-expected fiscal Q4 results. And the long-term outlook is confirmed.
Yet, the stock price dropped about 10% aftermarket. In the context of the impressive stock price increase over the last few weeks, this 10% decline isn't that important. But there's a gap between management's optimism and recent results.
